Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Criteria on Retinal Vein Occlusion Patients.

J Clin Med · 2025 · PMC12028246 · PMID 40283661

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although triple positivity and high-risk aPL profile were seen more frequently in patients who fulfilled the ACR/EULAR criteria, differences did not reach statistical significance ( Table 3 ). 3.3.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.